AVIEW vs eMurmur Heart AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AVIEW

by Coreline Soft Co.

eMurmur Heart AI

by eMurmur

AI Verdict

AVIEW is designed for detailed diagnostic imaging analysis of CT scans, focusing on conditions like lung cancer, COPD, and coronary artery calcification. eMurmur Heart AI, conversely, specializes in the automated analysis of heart and lung sounds via auscultation for detecting murmurs and providing hemodynamic insights. While both target cardiology and pulmonology, they address different diagnostic stages and data types, making them complementary rather than directly interchangeable.

Choose AVIEW if…

Choose AVIEW if your primary need is advanced, AI-driven quantitative analysis of CT scans for the early detection, diagnosis, and monitoring of lung pathologies and cardiovascular risks. This tool is ideal for radiology departments and pulmonology/cardiology specialists requiring precise measurements, 3D visualizations, and automated reporting for conditions like lung cancer, COPD, and coronary artery calcification.

View AVIEW →

Choose eMurmur Heart AI if…

Choose eMurmur Heart AI if your focus is on enhancing initial screening, continuous monitoring, and remote consultation through automated analysis of heart and lung sounds. This platform is best suited for primary care, telehealth providers, and specialists who need a portable, hardware-agnostic solution to detect murmurs and other auscultation abnormalities, facilitating early intervention and longitudinal patient tracking.

View eMurmur Heart AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AVIEW	eMurmur Heart AI
Pricing	Subscription; one-off payment	Contact for quote
Deployment	Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker)	Web-based, Mobile App, API integration
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eMurmur Heart AI

eMurmur Heart AI offers mobile app and web portal access, along with hardware-neutral and stethoscope-agnostic compatibility, making it highly accessible and usable at the point of care and for telehealth. Its focus on live streaming and remote auscultation further enhances its utility for a broad range of clinicians in various settings.

Clinical Value

AVIEW

AVIEW offers comprehensive AI solutions for critical conditions like lung cancer, COPD, and coronary artery disease, providing quantitative analysis from CT scans for early detection, diagnosis, and monitoring. Its features like Lung-RADS scoring, emphysema quantification, and CAC scoring directly support established clinical guidelines and impact definitive diagnostic and treatment decisions.

Pricing & Value

AVIEW

AVIEW provides a more transparent pricing model, offering both one-off payment and subscription options based on the number of installations or users. This flexibility and clarity regarding the pricing structure offer more upfront information to potential buyers compared to eMurmur Heart AI's 'contact for pricing' approach.

Enterprise Readiness

AVIEW

AVIEW demonstrates superior enterprise readiness through its highly flexible deployment options, including cloud, hybrid, local hardware, and virtualized solutions, catering to diverse IT infrastructure needs. Its explicit integration with PACS/RIS/CIS systems is critical for seamless adoption within large hospital and imaging center radiology workflows.

Innovation

AVIEW

AVIEW demonstrates strong innovation by offering a comprehensive AI platform that extracts a wide array of quantitative and clinically relevant data from CT scans for multiple complex diseases, including lung cancer, COPD, coronary artery disease, and ILD. Its integration of Lung-RADS scoring, emphysema quantification, and advanced 3D visualizations represents a significant advancement in diagnostic precision and workflow automation in radiology.

Support & Docs

AVIEW

AVIEW appears to have more explicitly referenced user manuals and reference guides available, indicating a structured approach to documentation. Coreline Soft also provides a dedicated customer service email for inquiries and support, suggesting clear channels for assistance.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AVIEW	eMurmur Heart AI
Name	AVIEW	eMurmur Heart AI
Company	Coreline Soft Co.	CSD Labs
Primary Function Summary	AI platform for early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans.	AI-powered software for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights.
Key Diagnostic Focus	Lung nodule detection and characterization, emphysema quantification, coronary artery calcium (CAC) scoring, ILD pattern analysis from CT scans.	Automated heart and lung sound analysis, detection and classification of pathologic and innocent heart murmurs, hemodynamic insights.
Supported Specialties	Cardiology, Pulmonology, Radiology	Cardiology, Internal Medicine, Pulmonology
Specific Feature Example	AI-powered lung nodule detection and characterization (size, volume, type, location, Lung-RADS score)	Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes)

Videos

Demos, reviews, and walkthroughs featuring AVIEW and eMurmur Heart AI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific clinical problems or patient populations does each tool address most effectively, considering their distinct diagnostic modalities?

AVIEW by Coreline Soft focuses on quantitative analysis of CT scans for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification, primarily benefiting radiologists, pulmonologists, and cardiologists in assessing structural changes. eMurmur Heart AI by CSD Labs specializes in automated analysis of heart and lung sounds from auscultation, supporting cardiologists, internal medicine physicians, and pulmonologists in screening for murmurs and monitoring hemodynamic insights across pediatric and adult patients.

How do these tools integrate into existing clinical workflows and what level of interoperability can be expected with electronic health record (EHR) systems?

AVIEW offers workflow automation and integration with PACS/RIS/CIS, enabling comprehensive PDF reports and 3D visualizations directly within radiology workflows. eMurmur Heart AI provides a mobile app and web portal for access, supporting live streaming and remote auscultation for telehealth, with secure storage and playback of auscultation data, and can integrate into electronic patient files and hospital information systems.

Can you describe the specific diagnostic insights each tool provides and how they enhance precision in their respective areas?

AVIEW provides AI-powered lung nodule detection and characterization (size, volume, type, Lung-RADS score), emphysema quantification, and coronary artery calcium scoring, offering detailed anatomical and pathological insights from CT images. eMurmur Heart AI delivers automated detection and classification of pathologic and innocent heart murmurs, along with hemodynamic insights like loudness ratios of S1, systole, S2, and diastole, enhancing the interpretation of auscultation findings.

What features are available for tracking patient progression over time or maintaining an audit trail of diagnostic findings?

AVIEW includes follow-up registration and nodule matching for serial CT scans, enabling the tracking of changes in lung nodules and simplifying the diagnosis process by automatically comparing nodule size or location changes. eMurmur Heart AI supports the recording, secure storage, and playback of auscultation data, allowing for comparison of current and previous auscultation data for ongoing patient monitoring.

What are the key considerations for deploying these solutions across multiple clinical sites or a large healthcare network?

AVIEW offers flexible deployment options including cloud, hybrid, local hardware, or virtualized solutions, with pricing based on installations and users, accommodating various IT infrastructures and has been deployed in large-scale screening programs globally. eMurmur Heart AI's cloud-based, web, and mobile app deployment, combined with its hardware-neutral and stethoscope-agnostic compatibility, facilitates broad adoption across diverse clinical settings and supports remote auscultation for telehealth.

What is the expected learning curve for physicians and clinical staff to become proficient in using each tool effectively?

AVIEW generates 3D visualizations and comprehensive PDF reports from CT scans, which may require familiarization with interpreting these detailed AI-generated outputs within radiology workflows. eMurmur Heart AI utilizes a mobile app and web portal for automated sound analysis, which may involve adapting to digital auscultation workflows and interpreting AI-classified murmur and hemodynamic insights.